Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Gains from Investment Securities (2020)

Historic Gains from Investment Securities for Design Therapeutics (DSGN) over the last 1 years, with Q4 2020 value amounting to $1.7 million.

  • Design Therapeutics' Gains from Investment Securities changed N/A to $1.7 million in Q4 2020 from the same period last year, while for Dec 2020 it was $1.7 million, marking a year-over-year change of. This contributed to the annual value of $100000.0 for FY2024, which is 8571.43% down from last year.
  • As of Q4 2020, Design Therapeutics' Gains from Investment Securities stood at $1.7 million.
  • In the past 5 years, Design Therapeutics' Gains from Investment Securities registered a high of $1.7 million during Q4 2020, and its lowest value of $1.7 million during Q4 2020.